1. Home
  2. RCEL vs RFMZ Comparison

RCEL vs RFMZ Comparison

Compare RCEL & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • RFMZ
  • Stock Information
  • Founded
  • RCEL 2020
  • RFMZ 2021
  • Country
  • RCEL United States
  • RFMZ United States
  • Employees
  • RCEL N/A
  • RFMZ N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • RFMZ Trusts Except Educational Religious and Charitable
  • Sector
  • RCEL Health Care
  • RFMZ Finance
  • Exchange
  • RCEL Nasdaq
  • RFMZ Nasdaq
  • Market Cap
  • RCEL 310.6M
  • RFMZ 344.3M
  • IPO Year
  • RCEL N/A
  • RFMZ N/A
  • Fundamental
  • Price
  • RCEL $13.34
  • RFMZ $13.98
  • Analyst Decision
  • RCEL Hold
  • RFMZ
  • Analyst Count
  • RCEL 3
  • RFMZ 0
  • Target Price
  • RCEL $16.50
  • RFMZ N/A
  • AVG Volume (30 Days)
  • RCEL 121.5K
  • RFMZ 76.6K
  • Earning Date
  • RCEL 11-07-2024
  • RFMZ 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • RFMZ 7.43%
  • EPS Growth
  • RCEL N/A
  • RFMZ N/A
  • EPS
  • RCEL N/A
  • RFMZ 0.65
  • Revenue
  • RCEL $60,040,000.00
  • RFMZ N/A
  • Revenue This Year
  • RCEL $34.73
  • RFMZ N/A
  • Revenue Next Year
  • RCEL $54.61
  • RFMZ N/A
  • P/E Ratio
  • RCEL N/A
  • RFMZ $21.49
  • Revenue Growth
  • RCEL 32.24
  • RFMZ N/A
  • 52 Week Low
  • RCEL $7.51
  • RFMZ $11.28
  • 52 Week High
  • RCEL $18.93
  • RFMZ $14.57
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 68.02
  • RFMZ 42.29
  • Support Level
  • RCEL $12.58
  • RFMZ $13.90
  • Resistance Level
  • RCEL $13.82
  • RFMZ $14.11
  • Average True Range (ATR)
  • RCEL 0.82
  • RFMZ 0.13
  • MACD
  • RCEL 0.09
  • RFMZ -0.00
  • Stochastic Oscillator
  • RCEL 82.80
  • RFMZ 33.88

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.

RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: